RxDoctor Payments Data

Aaron Bjorn, DO

Family Medicine · Saint Louis, MONPI 1740281088

Payments from drug & device makers

$15,922in general payments, 2019–2025

Across 988 payments — averaging $16.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • AstraZeneca$1K
  • Lilly USA, LLC$1K
  • Pfizer$1K
  • Novo Nordisk$946
  • GSK$894
  • plus $6K from 54 others

What the payments were for

  • Food & beverage$15,872100%
  • Education$500%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)211$4,226
AstraZeneca82$1,498
Lilly USA, LLC65$1,061
Pfizer87$1,016
Novo Nordisk68$946
GSK77$894
Amgen35$556
Johnson & Johnson30$496
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC34$451
Takeda Pharmaceuticals U.S.A., Inc.32$450
Boehringer Ingelheim19$291
Abbott15$261
Biohaven Pharmaceuticals, Inc.32$261
Lundbeck LLC10$212
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)11$206
Otsuka America Pharmaceutical, Inc.11$196
Exact Sciences10$195
Supernus Pharmaceuticals, Inc.9$179
Amarin Pharma, Inc.11$165
Astellas Pharma US Inc11$154
Merck9$137
Antares Pharma, Inc.8$136
Vanda Pharmaceuticals Inc.5$130
Novartis6$123
Sumitomo Pharma America, Inc.5$99
Kowa Pharmaceuticals America, Inc.7$97
Axsome Therapeutics, Inc.4$90
Biohaven Pharmaceutical Holding Company Ltd.5$85
Almatica Pharma LLC5$79
Sanofi-aventis U.S. LLC5$74
Aimmune Therapeutics, Inc.4$73
Dexcom, Inc.4$68
Vifor Pharma, Inc.4$67
Currax Pharmaceuticals LLC3$63
Tris Pharma Inc4$63
Noven Therapeutics, LLC4$61
Gilead3$59
Alfasigma USA, Inc.4$56
Esperion Therapeutics, Inc.3$55
Nestle Healthcare Nutrition Inc.3$49
Bausch Health US, LLC2$42
OPKO Pharmaceuticals, LLC2$40
Valinor Pharma, LLC2$37
Bayer2$36
Sanofi Pasteur Inc.2$34
Teva Pharmaceuticals USA, Inc.2$31
Idorsia Pharmaceuticals US Inc2$30
Eisai Inc.2$30
Fresenius USA Marketing, Inc.2$28
Upsher-smith Laboratories LLC2$28
Sunovion Pharmaceuticals Inc.2$27
Viiv Healthcare Company1$23
Corium, LLC1$21
Nevro Corp.1$20
Xeris Pharmaceuticals, Inc.1$19
E.r. Squibb & Sons, L.L.C.1$17
Amneal Pharmaceuticals LLC1$16
Endo Pharmaceuticals Inc.1$15
Phathom Pharmaceuticals, Inc.1$15
Radius Health, Inc.1$13

How this compares

$15,922 in reported general payments places this provider in the 95th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$60,312
Medicare patients
151
Services billed
2,211

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide88$86,909
EliquisApixaban79$63,280
JardianceEmpagliflozin79$56,330
Trelegy ElliptaFluticasone/Umeclidin/Vilanter76$54,577
Breztri AerosphereBudesonide/Glycopyr/Formoterol50$34,828
FarxigaDapagliflozin Propanediol29$31,592
MounjaroTirzepatide29$31,547
TrulicityDulaglutide24$31,463
XareltoRivaroxaban25$23,522
Tresiba Flextouch U-100Insulin Degludec27$14,821
UbrelvyUbrogepant11$14,346
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog25$13,549
OxycontinOxycodone Hcl15$12,511
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog15$12,330
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen352$11,239

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$946$86,90988 claims
AstraZenecaBreztri Aerosphere, Farxiga$1,498$66,42079 claims
PfizerEliquis, Abrysvo$1,016$66,19890 claims
Lilly USA, LLCMounjaro, Trulicity$1,061$63,01153 claims
GSKTrelegy Ellipta, Arexvy$894$62,252105 claims
Boehringer IngelheimJardiance, Stiolto Respimat$291$62,15591 claims
Johnson & JohnsonXarelto$496$23,52225 claims
AbbVieUbrelvy$4,226$14,34611 claims
Astellas Pharma US IncMyrbetriq$154$10,14917 claims
MerckJanuvia$137$6,73712 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$16$2,563186 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →